The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro

Unique visitors: 446

Mika Okamoto, Masaaki ToyamaMasanori Baba

DOI
https://doi.org/10.1016/j.antiviral.2020.104902

Înregistrări online